Albert K Groen Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2018	Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
12/2017	Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert K Groen Research Topics

Disease

34	Insulin Resistance 02/2022 - 06/2006
25	Atherosclerosis 01/2020 - 01/2002
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 06/2006
20	Inflammation (Inflammations) 02/2022 - 06/2006
17	Obesity 02/2022 - 01/2007
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
11	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 01/2002
10	Body Weight (Weight, Body) 01/2021 - 02/2009
9	Cholestasis 01/2019 - 09/2006
8	Gallstones (Gallstone) 10/2021 - 01/2003
8	Hypercholesterolemia 01/2019 - 12/2006
6	Non-alcoholic Fatty Liver Disease 01/2022 - 06/2006
6	Liver Diseases (Liver Disease) 01/2019 - 08/2012
5	Fatty Liver 11/2020 - 06/2006
5	Dyslipidemias (Dyslipidemia) 01/2018 - 03/2010
4	Metabolic Diseases (Metabolic Disease) 01/2019 - 08/2014
4	Hyperglycemia 01/2015 - 01/2010
4	Hypertriglyceridemia 12/2014 - 07/2004
3	Hyperlipidemias (Hyperlipidemia) 12/2017 - 05/2008
3	Mucositis 01/2017 - 03/2016
3	Weight Loss (Weight Reduction) 04/2016 - 06/2005
3	Cholelithiasis 09/2015 - 01/2003
3	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 03/2015 - 06/2003
3	Hepatocellular Carcinoma (Hepatoma) 03/2014 - 09/2008
3	Sitosterolemia 03/2004 - 06/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 09/2006
2	Glucose Intolerance 01/2018 - 10/2016
2	Glycogen Storage Disease (Glycogenosis) 12/2017 - 12/2010
2	Atherosclerotic Plaque (Atheroma) 11/2017 - 01/2017
2	Necrosis 01/2016 - 01/2016
2	Hyperinsulinism (Hyperinsulinemia) 01/2014 - 08/2012
2	Fibrosis (Cirrhosis) 10/2013 - 01/2012

Drug/Important Bio-Agent (IBA)

49	CholesterolIBA 10/2021 - 01/2002
30	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 09/2003
25	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2009
21	LipidsIBA 10/2021 - 06/2006
13	Insulin (Novolin)FDA Link 01/2022 - 01/2009
12	Triglycerides (Triacylglycerol)IBA 10/2021 - 06/2006
8	Proteins (Proteins, Gene)FDA Link 09/2021 - 04/2006
8	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2011 - 06/2003
7	SterolsIBA 10/2017 - 06/2003
7	N- (5- adamantane- 1- yl- methoxy- pentyl)deoxynojirimycinIBA 01/2012 - 09/2008
6	Lipoproteins (Lipoprotein)IBA 10/2021 - 07/2004
6	Fatty Acids (Saturated Fatty Acids)IBA 04/2021 - 09/2003
6	Adenosine Triphosphate (ATP)IBA 12/2016 - 06/2003
6	GlycosphingolipidsIBA 01/2012 - 09/2008
5	IsotopesIBA 01/2021 - 08/2012
5	Biomarkers (Surrogate Marker)IBA 06/2020 - 10/2013
5	Pharmaceutical PreparationsIBA 01/2019 - 01/2012
5	Volatile Fatty AcidsIBA 12/2018 - 01/2014
4	CytokinesIBA 02/2022 - 01/2016
4	ApolipoproteinsIBA 10/2021 - 05/2006
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 03/2014
4	Butyrates (Butyrate)IBA 12/2020 - 10/2012
4	Phytosterols (Plant Sterols)IBA 08/2020 - 06/2003
4	CitrullineIBA 06/2020 - 03/2016
4	GlucocorticoidsIBA 01/2019 - 05/2010
4	Apolipoproteins E (ApoE)IBA 01/2018 - 04/2006
4	LDL Receptors (LDL Receptor)IBA 10/2016 - 05/2010
4	Prednisolone (Predate)FDA LinkGeneric 08/2014 - 05/2010
4	Blood Glucose (Blood Sugar)IBA 01/2014 - 03/2010
4	Liver X ReceptorsIBA 01/2013 - 01/2004
4	ceramide glucosyltransferaseIBA 05/2010 - 09/2008
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2015
3	Phospholipids (Phosphatides)FDA LinkGeneric 10/2021 - 10/2007
3	LDL CholesterolIBA 11/2020 - 03/2016
3	BilirubinIBA 01/2019 - 12/2006
3	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 03/2016
3	Dietary Fiber FDA Link 07/2015 - 01/2014
3	LeptinIBA 08/2012 - 01/2007
3	CarbohydratesIBA 12/2010 - 06/2006
3	EnzymesIBA 05/2010 - 02/2009
3	Apolipoproteins AIBA 05/2008 - 09/2006
2	Chenodeoxycholic Acid (Chenix)FDA Link 01/2021 - 01/2017
2	Liraglutide FDA Link 01/2021 - 12/2016
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 12/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2020
2	Cholic AcidIBA 01/2021 - 09/2003
2	oxidized low density lipoproteinIBA 11/2020 - 12/2006
2	Vancomycin FDA LinkGeneric 01/2019 - 04/2014
2	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 01/2019 - 01/2016
2	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 10/2011
2	trimethyloxamine (trimethylamine N-oxide)IBA 01/2018 - 12/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 12/2017
2	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 01/2018 - 04/2015
2	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2017 - 12/2010
2	guar gum (guaran)IBA 01/2015 - 01/2014
2	Liver GlycogenIBA 12/2013 - 12/2010
2	HDL LipoproteinsIBA 10/2011 - 01/2008
2	PPAR deltaIBA 10/2009 - 03/2005
2	Apolipoprotein C-IIIIBA 05/2008 - 10/2006
2	HDL CholesterolIBA 01/2008 - 04/2006
2	Stearoyl-CoA DesaturaseIBA 06/2007 - 01/2007
2	Lipoprotein-XIBA 01/2007 - 12/2006
2	Apolipoproteins B (ApoB)IBA 12/2006 - 01/2006

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2006
10	Fecal Microbiota Transplantation 02/2022 - 01/2017
3	Bariatric Surgery 02/2022 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2017 - 03/2016
2	Radiotherapy 01/2017 - 01/2017